Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor for the treatment of fibrotic diseases. In addition, it develops gastrointestinal targeted ROCK inhibitor to treat crohn's disease-associated fibrosis; discoidin domain receptors (DDRs) inhibitor for the treatment of multiple fibrotic conditions; and RXC006, a porcupine inhibitor targeting fibrotic diseases, including idiopathic pulmonary fibrosis. The company has a research collaboration agreement with Jazz Pharmaceuticals plc to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase pathway. Redx Pharma Plc was incorporated in 2010 and is based in Macclesfield, the United Kingdom. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of REDX PHARMA PLC.
REDX PHARMA PLC business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of REDX PHARMA PLC are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of REDX PHARMA PLC , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of REDX PHARMA PLC including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of REDX PHARMA PLC and all latest updates of the company are provided.
The 2025 version of REDX PHARMA PLC report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 REDX PHARMA PLC- Key Facts
2.2 REDX PHARMA PLC- Geographic Locations
2.3 REDX PHARMA PLC- Subsidiaries and Affiliates
2.4 REDX PHARMA PLC- Business Divisions
2.5 REDX PHARMA PLC- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. REDX PHARMA PLC Strategic Analysis Review
3.1 REDX PHARMA PLC- Key Strategies
3.2 REDX PHARMA PLC- Company Outlook Statement
3.3 REDX PHARMA PLC- SWOT Analysis
3.3.1 REDX PHARMA PLC- Key Strengths
3.3.2 REDX PHARMA PLC- Key Weaknesses
3.3.3 REDX PHARMA PLC- Potential Opportunities
3.3.4 REDX PHARMA PLC- Potential Threats
3.4 REDX PHARMA PLC- Key Competitors
4. Business Description of the Company
4.1 REDX PHARMA PLC- Business Overview
4.2 REDX PHARMA PLC- Operations by Segment
5 Products and Services Details
5.1 REDX PHARMA PLC- Key Products
5.2 REDX PHARMA PLC- Key Service Areas
5.3 REDX PHARMA PLC- Key Brands
6 Company Developments
6.1 REDX PHARMA PLC- Company History
6.2 REDX PHARMA PLC- Latest Developments
7 Financial Analysis
7.1 REDX PHARMA PLC- Income Statements
7.2 REDX PHARMA PLC- Balance Sheet
7.3 REDX PHARMA PLC- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 REDX PHARMA PLC- Direct Competitors
8.2 REDX PHARMA PLC- Competitor Financial Ratios comparison
8.3 REDX PHARMA PLC- Competitor Stock Charts Comparison
8.4 REDX PHARMA PLC- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!